Clinical trial
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin…
NCT00412451 · ThromboGenics, Industry · Completed
Key facts
| NCT number | NCT00412451 |
|---|---|
| Title | A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) |
| Official title | A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical Posterior Vitreous Detachment (PVD) Induction for Treatment of DME. |
| Acronym | MIVI-II |
| Lead sponsor | ThromboGenics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug, Other |
| Interventions | ocriplasmin, Sham injection |
| Enrollment | 51 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Dec 18, 2006 |
| Last update posted | Dec 17, 2014 |
| Countries | Belgium, Germany, Italy, Netherlands, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: